Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Critical Care Medicine|January 25, 2003
Targeting high mobility group box 1 as a late-acting mediator of inflammationChristopher J Czura, Kevin J TraceyMolecular Medicine (Cambridge, Mass.)|March 24, 2007
CD38 and CD157: biological observations to clinical therapeutic targetsAmy Warenda Czura, Christopher J CzuraThe Journal of Infectious Diseases|June 7, 2003
High mobility group box-1 as a therapeutic target downstream of tumor necrosis factorChristopher J Czura, Huan Yang, Kevin J TraceyJournal of Endotoxin Research|January 22, 2004
Neural inhibition of inflammation: the cholinergic anti-inflammatory pathwayChristopher J Czura, Steven G Friedman, Kevin J TraceyCurrent Opinion in Clinical Nutrition and Metabolic Care|April 12, 2003
The gesture life of high mobility group box 1Steven G Friedman, Christopher J Czura, Kevin J TraceyJournal of Leukocyte Biology|March 1, 2005
The cytokine activity of HMGB1Huan Yang, Haichao Wang, Christopher J Czura, et al.Journal of Endotoxin Research|April 17, 2003
HMGB1 as a cytokine and therapeutic targetHuan Yang, Haichao Wang, Christopher J Czura, et al.Annals of the New York Academy of Sciences|December 17, 2008
Experimental therapeutic strategies for severe sepsis: mediators and mechanismsWilliam R Parrish, Margot Gallowitsch-Puerta, Christopher J Czura, et al.Frontiers in Veterinary Science|June 30, 2022
Transcutaneous Cervical Vagus Nerve Stimulation Induces Changes in the Electroencephalogram and Heart Rate Variability of Healthy Dogs, a Pilot StudyGibrann Castillo, Luis Gaitero, Sonja Fonfara, et al.Molecular Medicine (Cambridge, Mass.)|October 23, 2003
The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulationValentin A Pavlov, Hong Wang, Christopher J Czura, et al.Pageof 4